discord retatrutide Retatrutide: Comprehensive Safety and Clinical Data Retatrutide, an experimental weight-loss drug,

Severe persistent abdominal pain, repeated vomiting with inability to maintain fluids, symptoms of serious dehydration, or signs of a severe allergic reaction require prompt medical attention

The compound demonstrates extended stability with a prolonged half-life, making it suitable for weekly intervals in research protocols

For context, only 4.2% of placebo participants achieved complete pain freedom

10.1016/j.ebiom.2021.103242 25 MaoX.XuJ.WangW.LiangC.HuaJ.LiuJ.et al (2021)

The honest answer: Retatrutide looks more powerful on headline weight-loss potential, but there is no true head-to-head trial against CagriSema yet